Oslo, 12 April 2021: In connection with the Annual General Meeting of Ultimovacs ASA to be held on 15 April 2021, Jónas Einarsson, Chair of the Board of Directors, has so far received proxy based voting rights without voting instructions for 8,278,716 shares, representing 25.87% of the total voting rights in the company.
With the addition of the 1,498,913 shares controlled by Radforsk, Jónas Einarsson thus represents a total of 9,777,629 shares. This corresponds to 30.55% of the company’s total number of shares and votes in connection with the company’s ordinary Annual General Meeting.
The proxies are only valid for the Annual General Meeting on 15 April 2021. This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.